Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Continuous versus group sequential analysis for post-market drug and vaccine safety surveillance.

Continuous versus group sequential analysis for post-market drug and vaccine safety surveillance. Biometrics. 2015 Sep; 71(3):851-8.

View in: PubMed

Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.